GIGABYTE
24.2.2020 16:02:10 CET | Business Wire | Press release
GIGABYTE was originally scheduled to exhibit its edge computing products, as well as data center solutions to seize the 5G opportunities at the Mobile World Congress (MWC) held at the end of February. Although the 2020 event is canceled by the GSMA, GIGABYTE made its show into a digital format, [GIGABYTE MWC Online](https://www.gigabyte.com/MWC/2020 ), allowing its partners, customers, and users to still see its latest developments for the 5G era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200224005042/en/
MWC is the world’s biggest exhibition for the telecommunications industry aimed to highlight how next-generation networks will form the basis of wide-reaching value creation and economic impact in the 5G era. GIGABYTE, being an enabler for digital era businesses to transform their core values seamlessly with the technology trends of tomorrow, wants to take the initiative to showcase its server solutions ready to be used as MEC (Multi-access Edge Computing) platforms to support the new generation of 5G technologies and services, leveraging its innovative hardware design together with NFV (Network Functions Virtualization) and open-source software stacks to meet the QoS requirements of 5G.
On The Edge of 5G
On [GIGABYTE MWC Online], the MEC products and solutions are embedded into an interactive map to illustrate how they fit into 5G scenarios of eMBB , URLLC , and mMTC . GIGABYTE offers one of industry’s most comprehensive server product lineups that can help businesses from different vertical markets to overcome the challenges of building data center infrastructure necessary for success in the 5G era. GIGABYTE’s G591-HS0, featuring support for up to 32 accelerator cards, can provide powerful compute capabilities to build a combined MEC / VR stitching / processing server, which allows for high resolution videos to be processed and stored locally on the baseband unit, therefore making it ideal for enabling live streaming of 8K video or 360 VR at large spectator events. GIGABYTE also launched a 5G CrowdCell with LimeNET, to overcome 5G’s weaknesses of short range and signal drop-offs when hitting concrete walls, further completes the eMBB scenario of next-generation spectator experience. GIGABYTE’s H242-Z10 is a prime example of a compact GPU accelerated edge server platform that can be deployed to connect an intelligent vehicles network in order to overcome performance limitations previously constrained by onboard vehicle processing, or the latency and transmission bottlenecks of cloud computing. Its ultra-small footprint form factor can be mass deployed at scale at the far edge, which is perfect to also be used as an mMTC server to support an IoT network to enable a smart city.
Data Center Know-How for 5G Era
GIGABYTE will establish its vital place in the 5G ecosystem through MEC-optimized server platforms. Moreover, GIGABYTE has long been an exceptional server hardware and solution provider that helps businesses to build the data center infrastructure that can accelerate their innovation in 5G. GIGABYTE’s software-defined storage solution can consolidate existing media and effortlessly add new capacity that supports all main storage types (block, object or file) while simplifying management and reducing infrastructure costs; and GIGABYTE’s DNN (Deep Neural Networks) Training Appliance is an on-premises AI development platform that combines high performance GPU servers and a user-friendly GUI with powerful optimizations to effectively improve the accuracy and reduce the time required for DNN training. Both of the server solutions are for businesses of all sizes to transition effortlessly into 5G, which promises endless possibilities and is the foundation of a new digitally driven industrial revolution featuring an era of Intelligent Connectivity – the convergence of AI, Big Data, and IoT – powered by 5G.
5G and AI to Make a Breakthrough in 2020
According to Deloitte’s market trend report last year, 2020 will be the year for 5G and Artificial Intelligence to take off; and MWC echoes on its website that the market for AI is projected to reach $70 billion by 2020. Intelligent Connectivity is a pivotal evolution of 5G, and Artificial Intelligence is poised to have a transformative effect on consumers, enterprises, and governments around the world.
GIGABYTE demonstrates on [GIGABYTE MWC Online] an eMBB scenario in which higher density, greater performance, and feature-rich computing can help accelerate applications that require increased bandwidth. As an NVIDIA EGX platform builder, GIGABYTE is able to showcase a secure, cloud native edge computing platform for IoT, AI, 3D, XR and beyond, featuring an integrated hardware and software stack which can be used to quickly & easily deploy ready-to-use containers and AI frameworks from NGC (NVIDIA GPU Cloud). And GIGABYTE’s AERO series laptop is the world’s first laptop powered by Microsoft Azure AI. Through machine learning, Azure will assist the AERO laptop to optimize system settings and control CPU & GPU’s power consumption to effectively improve users working environment, and ultimately define what a laptop should perform in the Intelligent Connectivity era of 5G.
Find Your 5G Edge
MEC is a key technology for 5G to come to its full implementation, and GIGABYTE wants to use [GIGABYTE MWC Online] as a portal to share its expert know-how and critical products and solutions, and showcase its data center knowledge that will help you "Find Your 5G Edge" to vindicate its capability to "Upgrade Your Life".
By February 24th , the website will be fully accessible for everyone to explore edge computing and 5G. GIGABYTE has transformed its MWC exhibition into an online experience, including filming marketing and product experts’ short footages to provide insights and share perspectives. Partners and customers who might have hoped to connect with GIGABYTE to discuss 5G possibilities can do so by filling out a short online form, and visitors and users can participate in an online event to learn more about GIGABYTE’s solutions and win an NVMe 1TB SDD.
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005042/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom